Literature DB >> 12889220

Non organ based laboratory markers in systemic sclerosis.

N J McHugh1, O Distler, R Giacomelli, G Riemekasten.   

Abstract

Candidate markers for endothelial cell, lymphocyte and fibroblast function in systemic sclerosis have been reviewed. Autoantibody measurement and general inflammatory markers were considered the minimum requirements, with other markers needing further evaluation.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12889220

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


  8 in total

1.  Targeting activated T cells: successful use of anti-CD25 monoclonal antibody basiliximab in a patient with systemic sclerosis.

Authors:  H U Scherer; G-R Burmester; G Riemekasten
Journal:  Ann Rheum Dis       Date:  2006-09       Impact factor: 19.103

Review 2.  The pathogenesis of systemic sclerosis revisited.

Authors:  Matthias Geyer; Ulf Müller-Ladner
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

Review 3.  Biomarkers in systemic sclerosis.

Authors:  Susan V Castro; Sergio A Jimenez
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

Review 4.  [Vascular changes in the pathogenesis of systemic sclerosis].

Authors:  J H W Distler; J R Kalden; S Gray; O Distler
Journal:  Z Rheumatol       Date:  2004-12       Impact factor: 1.372

5.  Evaluating hand in systemic sclerosis.

Authors:  Didem Arslan Tas; Eren Erken; Hakan Sakalli; A Eftal Yucel
Journal:  Rheumatol Int       Date:  2011-11-17       Impact factor: 2.631

6.  The arthropathy of systemic sclerosis: a 12 month prospective clinical and imaging study.

Authors:  Giovanni La Montagna; Antonio Sodano; Vittorio Capurro; Domenico Malesci; Gabriele Valentini
Journal:  Skeletal Radiol       Date:  2004-09-17       Impact factor: 2.199

7.  Angiogenin and SDF-1α serum concentration in patients with systemic sclerosis in relation to clinical status.

Authors:  Bożena Dziankowska-Bartkowiak; Zofia Gerlicz-Kowalczuk; Elżbieta Waszczykowska
Journal:  Arch Med Sci       Date:  2011-03-08       Impact factor: 3.318

8.  Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension.

Authors:  Paola Di Benedetto; Giuliana Guggino; Giovanna Manzi; Piero Ruscitti; Onorina Berardicurti; Noemi Panzera; Nicolò Grazia; Roberto Badagliacca; Valeria Riccieri; Carmine Dario Vizza; Ganna Radchenko; Vasiliki Liakouli; Francesco Ciccia; Paola Cipriani; Roberto Giacomelli
Journal:  Arthritis Res Ther       Date:  2020-06-01       Impact factor: 5.156
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.